{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:11:58Z","timestamp":1791911518500,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.clgc.2023.07.013","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T12:09:59Z","timestamp":1690891799000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools"],"prefix":"10.1016","volume":"22","author":[{"given":"Michelle R.","family":"Downes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen N.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lajkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6801-3633","authenticated-orcid":false,"given":"Lisa J.","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2406-5370","authenticated-orcid":false,"given":"Eva","family":"Hollemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4032-6120","authenticated-orcid":false,"given":"Antonio","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2176-9102","authenticated-orcid":false,"given":"Geert J.L.H.","family":"van Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Iczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8640-5786","authenticated-orcid":false,"given":"Theodorus H.","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2023.07.013_bib0001","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.eururo.2019.09.027","article-title":"Predicting prostate cancer death with different pretreatment risk stratification tools: a head-to-head comparison in a nationwide cohort study","volume":"77","author":"Zelic","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0002","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clgc.2023.07.013_bib0003","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2016.08.065","article-title":"The CAPRA score at 10 years: contemporary perspectives and analysis of supporting studies","volume":"71","author":"Brajtbord","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0004","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/his.13747","article-title":"Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set","volume":"74","author":"Masoomian","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.clgc.2023.07.013_bib0005","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/his.14658","article-title":"Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies","volume":"80","author":"Rijstenberg","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.clgc.2023.07.013_bib0006","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejca.2020.09.016","article-title":"Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy","volume":"148","author":"Downes","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2023.07.013_bib0007","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0008","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/modpathol.2016.49","article-title":"Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy","volume":"29","author":"Kweldam","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pros.24279","article-title":"Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease","volume":"82","author":"Ma","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.clgc.2023.07.013_bib0011","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","article-title":"Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort","volume":"50","author":"Trudel","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2023.07.013_bib0012","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00428-022-03301-y","article-title":"Alternative prostate cancer grading systems incorporating percent pattern 4\/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy","volume":"480","author":"Seyrek","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clgc.2023.07.013_bib0013","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/JU.0000000000000316","article-title":"Impact of cribriform pattern and intraductal carcinoma on Gleason 7 prostate cancer treated with external beam radiotherapy","volume":"202","author":"Tom","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0014","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0015","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/s41379-022-01111-w","article-title":"Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification","volume":"35","author":"Yu","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0016","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","article-title":"ISUP Consensus definition of cribriform pattern prostate cancer","volume":"45","author":"van der Kwast","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0017","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1464-410X.2012.11400.x","article-title":"Prognostic value of the CAPRA clinical prediction rule: a systematic review and meta-analysis","volume":"111","author":"Meurs","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2023.07.013_bib0018","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.juro.2007.07.043","article-title":"Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients","volume":"178","author":"May","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0019","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jnci\/djp122","article-title":"Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis","volume":"101","author":"Cooperberg","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clgc.2023.07.013_bib0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/COC.0000000000000037","article-title":"Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic tool for prediction of metastases and prostate cancer-specific mortality in patients treated with external beam radiation therapy","volume":"39","author":"Vainshtein","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0021","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/his.13938","article-title":"Gleason grade patterns in nodal metastasis and corresponding prostatectomy specimens: impact on patient outcome","volume":"75","author":"Downes","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.clgc.2023.07.013_bib0022","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","article-title":"Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome","volume":"136","author":"Iczkowski","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0023","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2021.09.005","article-title":"Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason score 7 prostate cancer with cribriform Gleason pattern 4","volume":"118","author":"Chen","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clgc.2023.07.013_bib0024","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/his.13893","article-title":"Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens","volume":"75","author":"Hollemans","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.clgc.2023.07.013_bib0025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.euf.2021.04.016","article-title":"Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2","volume":"7","author":"Leo","year":"2021","journal-title":"Eur Urol Focus"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323001829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323001829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:37:33Z","timestamp":1761565053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767323001829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1558767323001829"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2023.07.013","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2023.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}